Jonathan Rende, Chief Research & Development Officer at CASTLIGHT HEALTH, INC. (CSLT), sold 16,572 shares at $4.25 ($70K) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market sale of $70k CSLT by Chief Research & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.25 | 8,286 | $35K | 50.0% |
| 2 | $4.25 | 8,286 | $35K | 50.0% |
| Total | $4.25 avg | 16,572 | $70K | 100% |
| Filing → |
| CSLT | SELL | 2016-05-17 | $205K | — | Filing → |